Home > Cashflow Statement > SAMRAT PHARMACHEM

SAMRAT PHARMACHEM
Cash Flow from Financing Activities

    Back to Cashflow Statement
SAMRAT PHARMACHEM is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

SAMRAT PHARMACHEM Last 5 Year Cash Flow from Financing Activities History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹0.48 Cr₹-11 Cr₹9.60 Cr₹-1.95 Cr₹-1.89 Cr

What is the latest Cash Flow from Financing Activities ratio of SAMRAT PHARMACHEM ?

The latest Cash Flow from Financing Activities ratio of SAMRAT PHARMACHEM is ₹0.48 Cr based on Mar2025 Standalone results.
Year Cash Flow from Financing Activities
Mar2025₹0.48 Cr
Mar2024₹-11 Cr
Mar2023₹9.60 Cr
Mar2022₹-1.95 Cr
Mar2021₹-1.89 Cr

How is Cash Flow from Financing Activities of SAMRAT PHARMACHEM Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹0.48 Cr
Positive
Mar2024 ₹-11 Cr
Negative
Mar2023 ₹9.60 Cr
Positive
Mar2022 ₹-1.95 Cr
Negative
Mar2021 ₹-1.89 Cr -

Compare Cash Flow from Financing Activities of peers of SAMRAT PHARMACHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM ₹64.5 Cr -1.1% 3.2% -39.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,018.0 Cr -2.3% -8.5% -3% Stock Analytics
DIVIS LABORATORIES ₹162,454.0 Cr 5.3% -3.4% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,702.0 Cr 3.7% -4.9% 26% Stock Analytics
DR REDDYS LABORATORIES ₹102,830.0 Cr 1.2% -4.2% 5.3% Stock Analytics
CIPLA ₹99,325.0 Cr 2.4% -7.2% -18.1% Stock Analytics


SAMRAT PHARMACHEM Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM

-1.1%

3.2%

-39.9%

SENSEX

5.8%

-1.7%

1.2%


You may also like the below Video Courses